Abbott Laboratories (ABT) and Allied Healthcare Products Inc. (NASDAQ:AHPI) Contrasting side by side

This is therefore a comparing of the risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation in Abbott Laboratories (NYSE:ABT) and Allied Healthcare Products Inc. (NASDAQ:AHPI). The two are both Medical Appliances & Equipment companies that compete with one another.

Earnings and Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Abbott Laboratories 78 5.04 N/A 1.49 51.49
Allied Healthcare Products Inc. 2 0.21 N/A -0.53 0.00

We can see in table 1 the earnings per share (EPS), top-line revenue and valuation of Abbott Laboratories and Allied Healthcare Products Inc.

Profitability

Table 2 has Abbott Laboratories and Allied Healthcare Products Inc.’s return on equity, net margins and return on assets.

Net Margins Return on Equity Return on Assets
Abbott Laboratories 0.00% 8.5% 3.8%
Allied Healthcare Products Inc. 0.00% -23.1% -17.5%

Risk and Volatility

Abbott Laboratories’s volatility measures that it’s 11.00% more volatile than Standard and Poor’s 500 due to its 1.11 beta. From a competition point of view, Allied Healthcare Products Inc. has a 0.13 beta which is 87.00% less volatile compared to Standard and Poor’s 500.

Liquidity

Abbott Laboratories’s Current Ratio and Quick Ratio are 1.6 and 1.1 respectively. The Current Ratio and Quick Ratio of its competitor Allied Healthcare Products Inc. are 2.4 and 0.8 respectively. Allied Healthcare Products Inc. therefore has a better chance of paying off short and long-term obligations compared to Abbott Laboratories.

Analyst Ratings

The table delivered features the ratings and recommendations for Abbott Laboratories and Allied Healthcare Products Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Abbott Laboratories 0 0 5 3.00
Allied Healthcare Products Inc. 0 0 0 0.00

Abbott Laboratories has a consensus price target of $90.17, and a 2.11% upside potential.

Insider and Institutional Ownership

The shares of both Abbott Laboratories and Allied Healthcare Products Inc. are owned by institutional investors at 76.2% and 11.5% respectively. About 0.7% of Abbott Laboratories’s share are held by insiders. On the other hand, insiders held about 62.88% of Allied Healthcare Products Inc.’s shares.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Abbott Laboratories 0.38% -1.28% 2.86% 5.11% 23.36% 5.78%
Allied Healthcare Products Inc. -8.82% -15.3% -16.22% -24.76% -38% -15.16%

For the past year Abbott Laboratories has 5.78% stronger performance while Allied Healthcare Products Inc. has -15.16% weaker performance.

Summary

On 8 of the 9 factors Abbott Laboratories beats Allied Healthcare Products Inc.

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company’s Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in North Chicago, Illinois.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.